COMPARISON OF OCULAR BLOOD FLOW CHANGES AT 30 MINUTES AFTER INTRAVITREAL INJECTION OF FARICIMAB, BROLUCIZUMAB, AND AFLIBERCEPT 2 mg FOR NEOVASCULAR AGE-RELATED MACULAR
Ocular blood flow significantly decreased 30 minutes postinjection in faricimab-treated, brolucizumab-treated, or aflibercept-treated eyes with neovascular age-related macular degeneration. Brolucizumab-treated eyes showed a significantly greater reduction in choroidal blood flow than aflibercept-treated eyes.
Authors
- Yoichiro Kojima (ORCID: https://orcid.org/0000-0001-7845-721X)
- Rikki Arai
- Masatoshi Haruta (ORCID: https://orcid.org/0000-0002-3151-582X)
- Kei Furushima
- Shotaro Dake
- Yu Matsuo (ORCID: https://orcid.org/0009-0004-0460-8950)
- Nobuhiro Kato (ORCID: https://orcid.org/0000-0002-4897-2058)
- Kazunori Sato (ORCID: https://orcid.org/0000-0002-4292-3095)
- Shigeo Yoshida (ORCID: https://orcid.org/0000-0003-1049-8909)
Institutions
- Kurume University (JP)
Publication Details
- Journal
- Retina
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1097/iae.0000000000004561
- Citations
- 3
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.12